• STJ71062 (1µg/ml) staining of A431 (A) and (0. 3ug/ml) of HeLa (B) and MCF7 (C) cell lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.
  • STJ71062 (1µg/ml) staining of NIH3T3 (A) , KNRK (B) and MDCK (C) cell lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.
  • STJ71062 Flow cytometric analysis of paraformaldehyde fixed A431 cells (blue line) , permeabilized with 0. 5% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.

Anti-ARF1 antibody (C-Term) (STJ71062)

SKU:
STJ71062-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/WB/FC
Reactivity: Human/Mouse/Rat/Dog
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-ARF1 (C-Term) is suitable for use in ELISA, Western Blot and Flow Cytometry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: Peptide ELISA: antibody detection limit dilution 1:8000.
WB: Approx 18kDa band observed in lysates of cell lines A431, HeLa, MCF7, NIH3T3, KNRK and MDCK (calculated MW of 20.7kDa according to Human NP_001649.1, Mouse NP_031502.1 and Rat NP_071963
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: ARF1
Gene ID: 375
Uniprot ID: ARF1_HUMAN
Immunogen Region: C-Term
Accession Number: NP_001019397.1; NP_001649.1; NP_001019398.1; NP_001019399.1
Specificity: This antibody is expected to recognize all four reported isoforms.
Immunogen Sequence: EGLDWLSNQLRNQK
Function Small GTPase involved in protein trafficking between different compartments. Modulates vesicle budding and uncoating within the Golgi complex. In its GTP-bound form, triggers the recruitment of coatomer proteins to the Golgi membrane. The hydrolysis of ARF1-bound GTP, which is mediated by ARFGAPs proteins, is required for dissociation of coat proteins from Golgi membranes and vesicles. The GTP-bound form interacts with PICK1 to limit PICK1-mediated inhibition of Arp2/3 complex activity.the function is linked to AMPA receptor (AMPAR) trafficking, regulation of synaptic plasticity of excitatory synapses and spine shrinkage during long-term depression (LTD). Plays a key role in the regulation of intestinal stem cells and gut microbiota, and is essential for maintaining intestinal homeostasis. Plays also a critical role in mast cell expansion but not in mast cell maturation by facilitating optimal mTORC1 activation. (Microbial infection) Functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase.
Protein Name Adp-Ribosylation Factor 1
Database Links Reactome: R-HSA-1660499
Reactome: R-HSA-1660514
Reactome: R-HSA-167590
Reactome: R-HSA-199992
Reactome: R-HSA-2132295
Reactome: R-HSA-432720
Reactome: R-HSA-432722
Reactome: R-HSA-6807878
Reactome: R-HSA-6811434
Reactome: R-HSA-6811438
Reactome: R-HSA-8950505
Reactome: R-HSA-9845576
Cellular Localisation Golgi Apparatus Membrane
Lipid-Anchor
Cytoplasmic Side
Synapse
Synaptosome
Postsynaptic Density
In The Gdp-Bound Form
Associates Transiently With The Membranes Via Its Myristoylated N-Terminus Where Guanine Nucleotide-Exchange Factor (Gef)-Mediated Nucleotide Exchange Occurs
Following Nucleotide Exchange
The Gtp-Bound Form Undergoes A Conformational Change
Leading To The Exposure Of A Myristoylated N-Terminal Amphipathic Helix That Provides Stable Membrane Anchorage
Alternative Antibody Names Anti-Adp-Ribosylation Factor 1 antibody
Anti-ARF1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance